Bio-Rad Laboratories, Inc. (BIO) vs Revvity, Inc. (RVTY)
RVTY leads on 8 of 13 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Revvity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIO vs RVTY
growth of $100 · last 30yBIO +1505.3%RVTY +906.2%BIO compounded faster
BIO RVTY
BIO vs RVTY: by the numbers
- •RVTY is the larger company ($11.29B vs $7.84B market cap).
- •BIO trades at the lower earnings multiple (47.77 vs 48.20 P/E).
- •RVTY converts more revenue to profit (8.30% vs 6.52% net margin).
- •BIO grew revenue faster over the past five years (-0.84% vs -8.12% CAGR).
- •RVTY pays a dividend (0.28% yield) while BIO does not currently pay one.
Which is better, BIO or RVTY?
Metric tally: BIO 5 · RVTY 8It depends on what you're optimizing for:
GrowthBIO(faster 5Y revenue CAGR)
QualityRVTY(higher ROIC)
Metrics side by side
Valuation
| Metric | BIO | RVTY |
|---|---|---|
| P/E ratio | 47.77 | 48.20 |
| Forward P/E | 29.10 | 17.37● |
| P/S ratio | 3.02● | 3.90 |
| P/B ratio | 1.14● | 1.58 |
| PEG ratio | — | 219.09 |
| EV / EBITDA | 18.50 | 17.88● |
| FCF yield | 4.57%● | 4.36% |
Profitability
| Metric | BIO | RVTY |
|---|---|---|
| Gross margin | 51.87% | 51.44% |
| Operating margin | 9.25% | 12.41%● |
| Net margin | 6.52% | 8.30%● |
| ROE | 2.46% | 3.35%● |
| ROIC | 2.04% | 2.82%● |
Dividends
| Metric | BIO | RVTY |
|---|---|---|
| Dividend yield | — | 0.28% |
| Payout ratio | — | 13.46% |
Growth (annualized)
| Metric | BIO | RVTY |
|---|---|---|
| Revenue CAGR (5Y) | -0.84%● | -8.12% |
| EPS CAGR (5Y) | -26.27% | 0.22%● |
| FCF CAGR (5Y) | -7.57%● | -16.70% |
| Total return CAGR (5Y) | -13.89% | -7.20%● |
Frequently asked
- Which is better, BIO or RVTY?
- It depends on your goal. growth: BIO (faster 5Y revenue CAGR); quality: RVTY (higher ROIC). Across all compared metrics, RVTY leads 8 to 5.
- Is BIO or RVTY cheaper?
- On trailing earnings, BIO is cheaper: BIO trades at a 47.77 P/E and RVTY at 48.20.
- Which has grown faster, BIO or RVTY?
- Over the past five years, BIO grew revenue faster — BIO at a -0.84% CAGR versus RVTY at -8.12%.
- Does BIO or RVTY pay a bigger dividend?
- RVTY pays a dividend (0.28% yield) while BIO does not currently pay one.
- Is BIO or RVTY more profitable?
- RVTY runs the higher net margin — BIO at 6.52% versus RVTY at 8.30%.
- Which has been the better investment, BIO or RVTY?
- Over the past 10-year, BIO delivered the higher annualized total return — BIO at 7.55% versus RVTY at 7.05%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioRevvity P/E ratioBio-Rad Laboratories dividend yieldRevvity dividend yieldBio-Rad Laboratories ROERevvity ROEBio-Rad Laboratories operating marginRevvity operating marginBio-Rad Laboratories revenue growthRevvity revenue growthBio-Rad Laboratories free cash flowRevvity free cash flow
Bio-Rad Laboratories & Revvity appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.